WHEN Stephane Castel first met with a group of Maori people and other Pacific Islanders in New Zealand to discuss his biotech company’s plans for genetic research, the reception was cautious.
Community members feared a repeat of past exploitations where researchers profited from their genetic material without regard for their welfare.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
